G.D./NNP Searle/NNP &/CC Co./NNP said/VBD 0/-NONE- the/DT Food/NNP and/CC Drug/NNP Administration/NNP approved/VBD the/DT sale/NN of/IN Kerlone/NNP ,/, a/DT hypertension/NN drug/NN developed/VBN */-NONE- by/IN a/DT joint/JJ venture/NN between/IN Searle/NNP and/CC a/DT French/JJ concern/NN ./.
Searle/NNP ,/, a/DT unit/NN of/IN Monsanto/NNP Co./NNP ,/, said/VBD 0/-NONE- the/DT ``/`` beta-blocker/NN ''/'' high-blood-pressure/JJ drug/NN Kerlone/NNP is/VBZ the/DT first/JJ product/NN 0/-NONE- *T*-1/-NONE- to/TO reach/VB the/DT market/NN through/IN Lorex/NNP Pharmaceuticals/NNP ,/, the/DT U.S./NNP company/NN jointly/RB owned/VBN */-NONE- by/IN Searle/NNP and/CC Synthelabo/NNP ,/, a/DT French/JJ pharmaceutical/JJ concern/NN owned/VBN */-NONE- by/IN France/NNP 's/POS L'Oreal/NNP S.A/NNP ./.

